Cargando…

Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study

BACKGROUNDS/AIMS: Fewer reports have been published regarding hepatectomy patients with solitary hepatocellular carcinoma (HCC) who received immunotherapeutic agents as adjuvant therapy. We evaluated the safety and efficacy of ex vivo-expanded allogenic natural killer (NK) cells in those patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jong Man, Cho, Sung Yoo, Rhu, Jinsoo, Jung, Miyoung, Her, Jung Hyun, Lim, Okjae, Choi, Gyu-Seong, Shin, Eui-Cheol, Hwang, Yu-Kyeong, Joh, Jae-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Hepato-Biliary-Pancreatic Surgery 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180393/ https://www.ncbi.nlm.nih.gov/pubmed/34053923 http://dx.doi.org/10.14701/ahbps.2021.25.2.206

Ejemplares similares

Present and Future of Allogeneic Natural Killer Cell Therapy
por: Lim, Okjae, et al.
Publicado: (2015)

GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
por: Lim, Okjae, et al.
Publicado: (2013)

Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
por: Jo, Sung Jun, et al.
Publicado: (2022)

Intraoperative Ultrasonography as a Guidance for Dividing Bile Duct During Laparoscopic Living Donor Hepatectomy
por: Rhu, Jinsoo, et al.
Publicado: (2019)

Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations
por: Yun, Sang Oh, et al.
Publicado: (2023)

Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis
por: Kim, Jong Man, et al.
Publicado: (2022)

Postoperative Health Status and Quality of Life After Pure Laparoscopic Donor Hepatectomy for Living Donor Liver Transplantation
por: Cho, Chan Woo, et al.
Publicado: (2022)

Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma
por: Choi, Young Bae, et al.
Publicado: (2019)

4101 Creating a Culturally Sensitive Report Card for African American (AA) Kidney Transplant Candidates
por: McKinney, Warren, et al.
Publicado: (2020)

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
por: Jung, Daun, et al.
Publicado: (2021)

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
por: Kim, Minjeong, et al.
Publicado: (2021)

Long-Term Outcomes of Liver Transplantation in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Comparison with Portal Vein Tumor Thrombus
por: Lee, Ji Soo, et al.
Publicado: (2023)

Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer
por: Choi, Jung-Won, et al.
Publicado: (2019)

Ex situ hepatectomy and liver autotransplantation for a treating giant solitary fibrous tumor: A case report
por: Sun, Zhongquan, et al.
Publicado: (2019)

Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience
por: Kim, Sang Jin, et al.
Publicado: (2021)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Prediction model for early graft failure after liver transplantation using aspartate aminotransferase, total bilirubin and coagulation factor
por: Rhu, Jinsoo, et al.
Publicado: (2021)

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Early use of everolimus improved renal function after adult deceased donor liver transplantation
por: Lee, Seohee, et al.
Publicado: (2021)

3D Printing Model of Abdominal Cavity of Liver Transplantation Recipient to Prevent Large-for-Size Syndrome
por: Park, Sunghae, et al.
Publicado: (2022)

Tablet or capsule form of generic mycophenolate mofetil (My-Rept(®)) after liver transplantation: a prospective randomized trial
por: Kim, Jong Man, et al.
Publicado: (2019)

Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2021)

Application of three-dimensional printing for intraoperative guidance during liver resection of a hepatocellular carcinoma with sophisticated location
por: Rhu, Jinsoo, et al.
Publicado: (2021)

Author Correction: The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study
por: Oh, Young Ju, et al.
Publicado: (2023)

Clinical impact of anatomical resection on long-term outcomes after hepatectomy for primary solitary hepatocellular carcinoma with or without preoperative positron emission tomography positivity
por: Cho, Chan Woo, et al.
Publicado: (2020)

Laparoscopy of hepatocellular carcinoma is helpful in minimizing intra-abdominal adhesion during salvage transplantation
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Feasibility of laparoscopic liver resection for liver cavernous hemangioma: A single-institutional comparative study
por: Shin, Younghuen, et al.
Publicado: (2020)

Elderly Hepatocellular Carcinoma Patients: Open or Laparoscopic Approach?
por: Kim, Jong Man, et al.
Publicado: (2020)

Comparison of liver regeneration in laparoscopic versus open right hemihepatectomy for adult living donor liver transplantation
por: Yang, Jaehun, et al.
Publicado: (2020)

Early reoperation after adult living-donor liver transplantation is associated with poor survival
por: Lim, Manuel, et al.
Publicado: (2019)

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
por: Kim, Kyeong Deok, et al.
Publicado: (2021)

Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as “Antidiabesity” Agents Based on Repurposing and Morphing of WB-4101
por: Artasensi, Angelica, et al.
Publicado: (2022)

Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy
por: Min, Bokyung, et al.
Publicado: (2018)

Hepatic venous territory mapping in living donor liver transplantation using right liver graft: an objective parameter for venous reconstruction
por: Yang, Jaehun, et al.
Publicado: (2023)

Ventilator support in the pretransplant period predisposes early graft failure after deceased donor liver transplantation
por: Lee, Nuri, et al.
Publicado: (2023)

Upper thigh skeletal muscle index predicts outcomes in liver transplant recipients
por: Lim, Manuel, et al.
Publicado: (2023)

Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients
por: Kim, Sang Jin, et al.
Publicado: (2020)

Risk factors of silent allograft fibrosis 10 years post-pediatric liver transplantation
por: Rhu, Jinsoo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pj1esjch1oag6k2fp51kgemdll